Cite
HARVARD Citation
Hanon, O. et al. (2021). Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation. Heart. 107 (17), pp. 1376-1382. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hanon, O. et al. (2021). Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation. Heart. 107 (17), pp. 1376-1382. [Online].